Located on chromosome 5, SPRY4 is an inhibitor of protein kinase pathway linked to TGCTs, whereas BAK1, which is located on chromosome 6, has been associated with this neoplasia since is a pro-apoptotic factor, whose expression is inhibited by KITLG-KIT pathway [38, 39]. Here, KITLG is linked to neoplasm.